Refractory Neuroblastoma Active Not Recruiting Phase 2 Trials for Olaparib (DB09074)

IndicationStatusPhase
DBCOND0047201 (Refractory Neuroblastoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs